ArticleFrontiers in immunology2025
Macrophage activation syndrome successfully treated with eculizumab and emapalumab: a case report.
Paola Faggioli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it